Avastin Account Orders Double, Reorder Rate Improves To 80%

The number of accounts ordering the oncologic rose from 1,500 to more than 3,000 in the second quarter, with 80% of accounts placing reorders. Genentech says the majority of Avastin's sales come from the front-line setting.

More from Archive

More from Pink Sheet